Last reviewed · How we verify
NCT04235361: MobEboDRC
Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRC
trial testing Differential RPA tests in Ebola Virus Disease in 500 participants. Status unknown.
30 June 2021
Quick facts
| Lead sponsor | University of Stirling |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 15 January 2021 |
| Primary completion | 30 June 2021 |
| Estimated completion | 30 July 2021 |
| Sites | 4 locations across Senegal, Germany, Canada, Democratic Republic of the Congo |
Drugs / interventions tested
- Differential RPA tests
Conditions studied
- Ebola Virus Disease — all drugs for Ebola Virus Disease →
- Malaria — all drugs for Malaria →
- Typhoid Fever — all drugs for Typhoid Fever →
- Dengue Fever — all drugs for Dengue Fever →
Sponsor
University of Stirling
Who can join
Eligibility, any sex, with Ebola Virus Disease or Malaria. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A mobile suitcase laboratory for EBOV point-of-care (POC) detection at Ebola treatment centers was successfully implemented in Guinea during the large Ebola virus disease (EVD) outbreak in West-Africa 2014-2015. It was shown that isothermal amplification (Recombinase Polymerase Amplification (RPA)) could be efficiently used to test suspect EVD cases and local teams were trained in and successfully deployed with this fast method. In the frame of this project we want to train teams in DRC and expand RPA testing capacity to the differentials recommended by the WHO. Existing RPA assays for all parameters will be included into a multistrip for simultaneous use. This will be integrated with a simple biosafe extraction method. Implementing this approach and testing in the ongoing EVD outbreak will provide teams in DRC with response capacity for future EVD outbreaks.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04235361
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ebola Virus Disease
Currently open trials in the same condition.
- NCT06100913 — Immunology of Ebola Vaccine · Phase 2 · active not recruiting
Other University of Stirling trials
Trials by the same sponsor.
- NCT06069427 — The Effect of Reducing Total Volume of Sprint Exercise on Circulating Levels of BDNF · NA · completed
- NCT06140693 — A Comparison of Affective Responses During Continuous and Interval Exercise · NA · active not recruiting
- NCT06141512 — Improvements in Aerobic Fitness With Exercise Training: the Role of Myokines · NA · active not recruiting
- NCT05601102 — danceSing Care Evaluation: Testing the Effectiveness · NA · completed
- NCT06255015 — Breastfeeding Planning Card Trial in Scotland · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04235361 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Stirling
- Last refreshed: 10 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04235361.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing